Santarus Inc. (SNTS) and Pharming Group (PHGUF.PK) Announce Submission of RUCONEST Biologics License Application to FDA
4/17/2013 9:28:41 AM
More...
|
Pharming Group (PHGUF.PK) Announces European Medicines Agency Approval of New Manufacturing Site for Ruconest®
3/28/2013 9:20:58 AM
More...
|
Pharming Group (PHGUF.PK) Reports on Preliminary Financial Results 2012
3/7/2013 9:44:20 AM
More...
|
Pharming Group (PHGUF.PK) Reports on Extraordinary General Meeting
2/28/2013 8:57:45 AM
More...
|
Pharming Group (PHGUF.PK) Announces $21.7 Million Financing
1/16/2013 7:17:41 AM
More...
|
Pharming Group (PHGUF.PK) Announces Receipt of $10 Million Milestone Payment
11/26/2012 7:27:56 AM
More...
|
Pharming Group (PHGUF.PK)-Santarus Inc. (SNTS) Ruconest Phase III Study Meets Primary Endpoint
11/7/2012 6:46:30 AM
More...
|
Pharming Group (PHGUF.PK) Reports on Financial Results First Half Year 2012
8/23/2012 9:02:21 AM
More...
|
Pharming Group (PHGUF.PK) Updates on Ongoing Call of First Tranche of EUR 10 Million Equity Working Capital Facility
8/20/2012 8:58:14 AM
More...
|
Pharming Group (PHGUF.PK) Draws First Tranche Under EUR10 Million Working Capital Facility
8/8/2012 8:19:01 AM
More...
|
|